- Home
- OTLK vs TISI Comparison
OTLK vs TISI Comparison
Compare OTLK & TISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- TISI
- Stock Information
- Founded
- OTLK 2010
- TISI 1973
- Country
- OTLK United States
- TISI United States
- Employees
- OTLK N/A
- TISI N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- TISI Other Consumer Services
- Sector
- OTLK Health Care
- TISI Consumer Discretionary
- Exchange
- OTLK Nasdaq
- TISI Nasdaq
- Market Cap
- OTLK 64.6M
- TISI 68.1M
- IPO Year
- OTLK 2016
- TISI N/A
- Fundamental
- Price
- OTLK $1.83
- TISI $17.36
- Analyst Decision
- OTLK Strong Buy
- TISI
- Analyst Count
- OTLK 5
- TISI 0
- Target Price
- OTLK $21.00
- TISI N/A
- AVG Volume (30 Days)
- OTLK 892.5K
- TISI 11.9K
- Earning Date
- OTLK 02-12-2025
- TISI 03-06-2025
- Dividend Yield
- OTLK N/A
- TISI N/A
- EPS Growth
- OTLK N/A
- TISI N/A
- EPS
- OTLK N/A
- TISI N/A
- Revenue
- OTLK N/A
- TISI $853,107,000.00
- Revenue This Year
- OTLK N/A
- TISI N/A
- Revenue Next Year
- OTLK $396.84
- TISI N/A
- P/E Ratio
- OTLK N/A
- TISI N/A
- Revenue Growth
- OTLK N/A
- TISI N/A
- 52 Week Low
- OTLK $0.87
- TISI $5.05
- 52 Week High
- OTLK $12.85
- TISI $26.77
- Technical
- Relative Strength Index (RSI)
- OTLK 39.18
- TISI 57.26
- Support Level
- OTLK $1.79
- TISI $16.00
- Resistance Level
- OTLK $2.26
- TISI $17.67
- Average True Range (ATR)
- OTLK 0.18
- TISI 1.25
- MACD
- OTLK 0.00
- TISI 0.08
- Stochastic Oscillator
- OTLK 6.09
- TISI 64.87
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About TISI Team Inc.
Team Inc is a provider of specialty industrial services, including inspection, engineering assessment and mechanical repair and remediation required in maintaining high temperature and high-pressure piping systems and vessels that are utilized in refining, petrochemicals, and others. The company operates in two segments namely Inspection and Heat Treating Group and Mechanical Services Group. Inspection and Heat Treating Group provides non-destructive testing services for the process, pipeline and power sectors and others. The Mechanical Services Group provides call-out and turnaround services under both on-stream and shut down circumstances.